Multiple Sclerosis: Immunopathology and Treatment Update

Author： Dargahi Narges Katsara Maria Tselios Theodore Androutsou Maria-Eleni de Courten Maximilian Matsoukas John Apostolopoulos Vasso

Publisher： MDPI

E-ISSN： 2076-3425|7|7|78-78

ISSN： 2076-3425

Source： Brain Sciences, Vol.7, Iss.7, 2017-07, pp. : 78-78

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiple Sclerosis: From Molecules to Treatment

By Broadley Simon A

International Journal of Molecular Sciences, Vol. 14, Iss. 4, 2013-04 ,pp. : 7598-7602

MDPI

Access to resources Recommend Favorite

Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis

By Kolb-Mäurer Annette Goebeler Matthias Mäurer Mathias

International Journal of Molecular Sciences, Vol. 16, Iss. 7, 2015-07 ,pp. : 14951-14960

MDPI

Access to resources Recommend Favorite

Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis

By Chiba Kenji Adachi Kunitomo

Pharmaceuticals, Vol. 5, Iss. 5, 2012-05 ,pp. : 514-528

MDPI

Access to resources Recommend Favorite

Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis—Report of Two Cases

By Rau Daniela Lang Michael Harth Andreas Naumann Markus Weber Frank Tumani Hayrettin Bayas Antonios

International Journal of Molecular Sciences, Vol. 16, Iss. 7, 2015-06 ,pp. : 14669-14676

MDPI

Access to resources Recommend Favorite

Multiple Sclerosis and Schizophrenia

By Arneth Borros M.

International Journal of Molecular Sciences, Vol. 18, Iss. 8, 2017-08 ,pp. : 1760-1760

MDPI

Access to resources Recommend Favorite